Market Overview

Regulus, Sanofi Present New Data Enhancing Preclinical Profile of RG-012 for Treatment of Renal Dysfunction in Alport Syndrome at ASN

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: News Press Releases

 

Related Articles (SNY + RGLS)